Catridecacog clinical trials
How each study uses catridecacog is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 3 Sept 2012 · NovoThirteen · EMEA/H/C/002284 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
12 studies that test it; most in 2003 (3)
| Year | Studies |
|---|---|
| 2003 | 3 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 0
Studies
Open first, then newest update. How each study uses catridecacog is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725CompletedPhase 3Novo Nordisk A/SNCT00978380Written as catridecacogHow we know
- Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart SurgeryCompletedPhase 2Novo Nordisk A/SNCT00914589Written as catridecacogHow we know
- Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited DeficiencyCompletedPhase 3Novo Nordisk A/SNCT00713648Written as catridecacogHow we know
- Safety of a Single Intravenous Dose of Recombinant Factor XIII in Children With Congenital FXIII A-subunit DeficiencyCompletedPhase 3Novo Nordisk A/SNCT01230021Written as catridecacogHow we know
- Safety and Pharmacokinetics of Recombinant Factor XIII in Patients With Congenital Factor Xlll DeficiencyCompletedPhase 1Novo Nordisk A/SNCT00056589Written as catridecacogHow we know
- Safety and Pharmacokinetics of Recombinant Factor XIII in Healthy VolunteersCompletedPhase 1Novo Nordisk A/SNCT01847989Written as catridecacogHow we know
- Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary BypassCompletedPhase 1Novo Nordisk A/SNCT02239146Written as catridecacogHow we know
- Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male SubjectsCompletedPhase 1Novo Nordisk A/SNCT01082406Written as catridecacogHow we know
- Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit DeficiencyCompletedPhase 3Novo Nordisk A/SNCT01253811Written as catridecacogHow we know
- A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative ColitisTerminatedPhase 2Novo Nordisk A/SNCT01706159Written as catridecacogHow we know
- Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese VolunteersCompletedPhase 1Novo Nordisk A/SNCT01153997Written as catridecacogHow we know
- Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy VolunteersCompletedPhase 1Novo Nordisk A/SNCT01848002Written as catridecacogHow we know
Codes
What other systems call catridecacog · ClinicalTrials.gg INT017410
- UNII (FDA) NU23Q531G1CATRIDECACOGConfirmed FDA, Wikidata
- RxNorm 1488293Confirmed FDA, Wikidata
- Wikidata Q16858452catridecacogConfirmed FDA, Wikidata
- NCI Thesaurus C174766CatridecacogOne source FDA
- DrugBank DB09310One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | NU23Q531G1 | CATRIDECACOG | Confirmed FDA, Wikidata |
| RxNorm | 1488293 | — | Confirmed FDA, Wikidata |
| Wikidata | Q16858452 | catridecacog | Confirmed FDA, Wikidata |
| NCI Thesaurus | C174766 | Catridecacog | One source FDA |
| DrugBank | DB09310 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.